Association of hepatitis B core antibody level and hepatitis B surface antigen clearance in HBeAg-negative patients with chronic hepatitis B
Predicting hepatitis B surface antigen (HBsAg) clearance is important for chronic hepatitis B (CHB) patients receiving pegylated interferon-alfa (Peg-IFN) therapy. We aimed to determine the predictive value of serum hepatitis B core antibody (anti-HBc) for HBsAg clearance. A total of 189 HBeAg-negat...
保存先:
| 主要な著者: | , , , , , , , , , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Taylor & Francis Group
2024-12-01
|
| シリーズ: | Virulence |
| 主題: | |
| オンライン・アクセス: | https://www.tandfonline.com/doi/10.1080/21505594.2024.2404965 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
